Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P166: Prognostic significance of eosinophil granule proteins in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

K. Amcoff1, Y. Cao2, Y. Zhulina1, M. Lampinen3, J. Halfvarson1, M. Carlson3*

1Örebro University, Department of Gastroenterology, Faculty of Medicine and Health, Örebro, Sweden, 2Örebro University, Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro, Sweden, 3Uppsala University, Department of Medical Sciences, Uppsala, Sweden

P167: Long-term outcomes of cyclosporine A and infliximab treatment for the management of steroid-refractory acute severe ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

E.M. Song1*, S.-H. Lee1, K. Chang1, S.W. Hwang1,2, S.H. Park1,2, D.-H. Yang1, J.-S. Byeon1, S.-J. Myung1, S.-K. Yang1,2, B.D. Ye1,2

1University of Ulsan College of Medicine, Asan Medical Center, Gastroenterology, Seoul, South Korea, 2University of Ulsan College of Medicine, Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea

P168: Predicting outcome in acute severe ulcerative colitis: Comparison of the Oxford, Edinburgh, Lindgren and endoscopic Mayo scoresECCO '18 Vienna
Year: 2018
Authors:

S. Bernardo*, S. Fernandes, A.R. Gonçalves, C. Baldaia, A. Valente, P. Moura Santos, L. Correia, J. Velosa

Hospital Santa Maria, Gastrenterology, Lisbon, Portugal

P169: Infliximab trough levels after induction therapy are predictive for infliximab efficacy in paediatric patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

K. van Hoeve1*, I. Hoffman1, E. Dreesen2, M. Ferrante3, A. Gils2, S. Vermeire3

1University Hospitals Leuven, Department of Paediatric gastroenterology, Leuven, Belgium, 2KU Leuven, Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium, 3University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium

P170: Azathioprine metabolite (6-TGN) levels within a defined therapeutic range are associated with lower faecal calprotectin in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Essmann*, C. Keil, M.P. Manns, O. Bachmann

Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany

P171: A multi-marker serum test predicts mucosal healing status in Crohn’s disease regardless of disease locationECCO '18 Vienna
Year: 2018
Authors:

G. D'Haens1*, D. Laharie2, W. Sandborn3, M. Hale4, V. Kondragunta4, K. Bray4, A. Jain4, S. Vermeire5

1Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, 2CHU Bordeaux, Bordeaux, France, 3University of California at San Diego, San Diego, USA, 4Prometheus Laboratories Inc., San Diego, USA, 5University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium

P172: Histological healing is associated with decreased clinical relapse in patients with ileal Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

B. Christensen1,2,3*, J. Erlich1, P. Gibson2, D.T. Rubin1

1University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, USA, 2The Alfred Hospital, Melbourne, Australia, 3The Royal Melbourne Hospital, Gastroenterology Department, Melbourne, Australia

P173: Danese’s “Red flag Instrument” for early Crohn’s disease referral may also pick up ulcerative colitis patients – a prospective studyECCO '18 Vienna
Year: 2018
Authors:

J. Roseira1*, H. Tavares de Sousa2, A. Marreiros3, J. Parra4, E. Coelho5, P. Caldeira6, T. Belo6, T. Gago2, A.C. Cunha6, L. Contente2, H. Guerreiro2

1Algarve University Hospital Centre, Gastroenterology, Algarve, Portugal, 2Algarve Hospital Centre, Gastroenterology, Algarve, Portugal, 3Universidade do Algarve, Biomedical Science Department, Algarve, Portugal, 4Algarve University Hospital Center, Pathology, Algarve, Portugal, 5Health Community Centres Organization, Algarve, Portugal, 6Algarve University Hospital Center, Gastroenterology, Algarve, Portugal

P174: Is IBD different in elderly?ECCO '18 Vienna
Year: 2018
Authors:

M. Boudabous*, A. Siala, L. Chtourou, L. Mnif, A. Amouri, N. Tahri

University of Sfax, Sfax, Tunisia

P175: Fatigue and its severity depends on demographic and clinical factors in the Polish population of patients with inflammatory bowel disease - results of a cross-sectional studyECCO '18 Vienna
Year: 2018
Authors:

A. Liebert1*, M. Gawron-Kiszka2, A. Budzyńska2, A. Gąsiorowska3, A. Gryglewska3, M. Wiśniewska-Jarosińska3, J. Kierkuś4, W. Czuber-Dochan5, M. Kłopocka1

1Nicolaus Copernicus University, Collegium Medicum in Bydygoszcz, Department of Vascular Diseases and Internal Medicine, Bydgoszcz, Poland, 2Department of Gastroenterology and Hepatology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland, 3Department of Gastroenterology Medical University of Lodz, Łódź, Poland, 4Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics The Children's Memorial Health Institute, Warszawa, Poland, 5Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, London, UK

P176: Improving quality of care through patient´s eyes: Results from IQCARO project focus groupsECCO '18 Vienna
Year: 2018
Authors:

D. Carpio1*, X. Calvet2, I. Vera3, F. Casellas4, L. Marin5, R. Saldaña6, L. Cea-Calvo7, B. Juliá7, M. Minguez8

1Complejo Hospitalario de Pontevedra, Gastroenterology Unit, Pontevedra, Spain, 2Hospital De Sabadell, Institut Universitari Parc Taulí, Digestive Unit, Sabadell, Spain, 3Hospital Universitario Puerta de Hierro, Servicio de Gastroenterologia, Madrid, Spain, 4Hospital Vall d´Hebron, Gastroenterology Department, Barcelona, Spain, 5Hospital Universitari Germans Trias i Pujol and CIBERehd, Gastroenterology Unit, Badalona, Spain, 6Spanish Association of patients with Crohn´s disease and Ulcerative colitis, Madrid, Spain, 7MSD Spain, Medical Department, Madrid, Spain, 8Unidad de Gastroenterología,Hospital General de Valencia, Valencia, Spain

P177: Prognostic factors for colectomy and acute severe colitis in paediatric ulcerative colitis: A systematic reviewECCO '18 Vienna
Year: 2018
Authors:

E. Orlanski-Meyer1*, M. Aardoom2, A. Ricciuto3, N. Carman3, L. de Ridder2, A. Griffiths3, D. Turner1

1Shaare Zedek Medical Center, The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel, 2Erasmus MC-Sophia Children’s Hospital, Pediatric Gastroenterology, Rotterdam, The Netherlands, 3Hospital for Sick Children, University of Toronto, Department of Paediatrics; Department of Gastroenterology, Hepatology and Nutrition, Toronto, Canada

P178: Sleep fragmentation measured by wearable device is an indicator of clinical disease activity in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

M.A. Sofia*, O. Yvellez, N. Zmeter, K. El Jurdi, J. Ollech, M.J. Andersen Jr., M. Aharoni Golan, D.M. Rodriquez, D.T. Rubin

University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, USA

P179: Visceral fat hypertrophy does not have an impact on the activity and severity of Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

L. Lucaciu1,2*, T. Mocan1,2, D.G. Duma3, A. Seicean1,2

1Iuliu Hatieganu University of Medicine and Pharmacy, Gastroenterology and Hepatology, Cluj-Napoca, Romania, 2Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania, 3County Clinical Emergency Hospital, Radiology, Cluj-Napoca, Romania

P180: Role of hydrosonography of small bowel in the detection of inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

M. Wahba1*, A. Farag2, M. Fawezi3, H. Okasha2

1Cairo University, Kasralainy School of Medicine, Cairo, Egypt, 2Cairo University, Cairo, Egypt, 3Cairo University, Cairo, Egypt

P181: A retrospective analysis of the clinical application of the multigene analysis test DiBiCol® to differentiate between ulcerative colitis and Crohn’s disease and Non-IBDECCO '18 Vienna
Year: 2018
Authors:

C. Admyre1*, T. Knittel1, A. Ost2, R. Lofberg3, A. Zargari1

1Index Pharmaceuticals, Stockholm, Sweden, 2Aleris Medilab, Department of Pathology and Cytology, Täby, Sweden, 3Karolinska Institute, Stockholm, Sweden

P182: Intestinal diffuse neuroendocrine system and proliferation indicators in prediction of non-specific ulcerative colitis occurrence and courseECCO '18 Vienna
Year: 2018
Authors:

M.A. Osadchuk1*, A.M. Osadchuk1, K.S. Solodenkova1, A.R. Babaeva2, V.A. Kim1

1I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation, 2Volgograd State Medical University, Volgograd, Russian Federation

P183: Clinical course for patients stopping treatment with biological compoundsECCO '18 Vienna
Year: 2018
Authors:

R. Eldandachi1, J. Björk1, M. Lördal2*

1Karolinska University Hospital, Gastroenterology Unit, Patient Area Gastroenterology, Dermatovenerology and Rheumatology, Stockholm, Sweden, 2Danderyds Hospital, Department of Medicine, Gastroenterology Unit, Stockholm, Sweden

P184: 3D endoanal ultrasound: diagnosis and follow-up of anal fistulas in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

S. Orlandi*, A. Massella, A. Variola, M. Fortuna, A. Geccherle

Multispecialistic Centre for Recto-Perineal Diseases (IBD Unit), Department of Gastroenterology, Ospedale Sacro Cuore Don Calabria., Negrar (Verona, Italy), Italy

P185: Natural history of Crohn’s disease postoperative recurrence in a referral centre in the era of biologics and therapeutic intensification based on early endoscopic findingsECCO '18 Vienna
Year: 2018
Authors:

A. Buisson1,2*, L. Cannon3, K. Umanskiy3, R.D. Hurst3, N.H. Hyman3, A. Sakuraba4, J. Pekow4, S. Dalal4, R.D. Cohen4, B. Pereira5, D.T. Rubin4

1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the Host, Clermont-Ferrand, France, 3University of Chicago Medicine, Department of Surgery, Chicago, USA, 4Inflammatory Bowel Disease Center University of Chicago Medicine, Chicago, USA, 5University Hospital, Biostatistics Unit, DRCI, Clermont-Ferrand, France